Home | News

News

Telomeres in mouse embryonic fibroblasts Scientific News
13.06.2019
EMBO Molecular Medicine. CNIO researchers find effective drug combinations for glioblastoma in mice Usually, scientists study the molecular biology of cancer to find new treatments, but sometimes, it...
CNIO building 10.06.2019 CNIO and ISCIII to co-organise the 2019-2020 master’s programme in bioinformatics and personalised medicine Personalised medicine, considered to be a powerful approach to diseases such as cancer, relies... Debate Victor Frankenstein 2019 Outreach to Society
03.06.2019
Debate ‘Modern science rescues Victor Frankenstein. Mary Shelley as a lover of science’ [In Spanish] On April 26, 2019, for Books’ Night, CNIO and “la Caixa” celebrated...
© Chema Madoz for CNIO ARTE Events
31.05.2019
CNIO Arte to be part of ‘Quantum’, an exhibition at CCCB in Barcelona On 6 June, the Spanish National Cancer Research Centre (CNIO) will be present in ‘Quantum’,...
Intestinal stem cells with URI, CNIO Basic Research
30.05.2019
Science. CNIO researchers discover a new way to protect against high-dose radiation damage Radiotherapy, a common treatment for cancer, is one of the most effective ways to destroy cancer...
radiotherapy 30.05.2019 CNIO discovers a new way to protect against high-dose radiation damage Scientists from the CNIO Growth Factors, Nutrients and Cancer Group publish in Science a discovery... Vídeo CNIO & The City: Cambiar el mundo Outreach to Society
22.05.2019
CNIO & The City: Changing the World [Subtitles available in English] Do you remember when you were thinking about studying science or...
CNIO & The City: Changing the world Outreach to Society
22.05.2019
2nd CNIO & The City comes to a close with video celebrating passion as a driving force in scientific development Although they often say adults tend to leave childhood easily behind, we keep two driving forces...
CNIO participates in an international study identifying hnRNP K as novel oncogene for most common types of blood cancer Basic Research
21.05.2019
JNCI. CNIO participates in an international study identifying hnRNP K as novel oncogene for most common types of blood cancer Miguel Gallardo, researcher and coordinator of the H12O-CNIO Haematological Malignancies Clinical...

Up